A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty

Completed

Conditions studied: Total Shoulder Arthroplasty, Glenohumeral Osteoarthritis

In brief

The proposed study aims to objectively assess 2-year clinical and radiographic results for the rate of glenoid component loosening in total shoulder arthroplasty (TSA). This retrospective radiographic review will provide evidence for equivalence or superiority in curtailing loosening, a known complication in arthroplasty, when a hemostatic agent is utilized in conjunction with cement at the glenoid.

Key facts

Study ID

NCT01726972

Run by

Western Orthopaedics Research and Education Foundation

People needed

41

Starts

2012-11-01

Expected to finish

2015-04-01

Last updated by the study team

2020-10-23

Who can join

Age: 21 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have completed at least 2 years follow-up following their total shoulder replacement
• Patients must have had radiographic imaging obtained at that 2 years

You may not qualify if…

• Patients less than 21 years of age
• Patients who have been imprisoned since the time of surgery
• Patients who are mentally impaired

Where it is running

• Study site — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.